Business
United States resumes Johnson & Johnson vaccine rollout following 10-day pause over blood clot concerns – ABC News
The United States can resume use of Johnson & Johnson’s COVID-19 vaccine immediately, top health regulators say, ending a 10-day pause to investigate the vaccine’s…
The United States can resume use of Johnson & Johnson’s COVID-19 vaccine immediately, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine’s link to extremely rare but potentially deadly blood clots.
Key points:
- The CDC panel voted 10-4 that the Johnson & Johnson COVID-19 vaccine be recommended for use in people 18 years of age and older
- Johnson & Johnson’s chief scientific officer Paul Stoffels said the committee’s recommendation was “an essential step toward continuing…
Continue Reading
-
Noosa News17 hours agoUnlawful wounding charges, Caloundra – Sunshine Coast
-
General19 hours agoCalifornia worker dead and hundreds arrested after cannabis farm raid
-
Business10 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
General23 hours agoBreaking: Man shot at shopping centre in Sydney's west